Our choice of the given dose of Klotho (10μg/Kg) was based on published data showing that this dose was sufficient to prevent or delay AKI to CKD progression and uremic cardiomyopathy in mice (63) and resulted in less kidney damage in mice with AKI (32). This evidence concerns the gene KL and acute kidney injury.